Media Response
August 1, 2016

Contact: Koko Mackin
205-220-2713

Birmingham, AL – Due to lack of strong clinical and scientific evidence, Blue Cross and
Blue Shield of Alabama will continue to not cover the type of artificial pancreas treatment (APT)
provided by Trina Health or other similar providers.
APT is not covered by Medicare or any other major third party insurer. The Centers for Medicare
and Medicaid Services (CMS) has issued “non-coverage” notices on the procedure for this
particular treatment.
The American Diabetes Association and major medical specialties including ophthalmology,
nephrology, and endocrinology have not published any statements validating the effectiveness of
this form of artificial pancreas treatment provided by Trina Health or other similar providers.
Additionally, there is currently insufficient medical evidence to show improvement patterns in
patients. For these reasons, Blue Cross opposed House Bill 415.
Blue Cross is continually open to reviewing clinical data regarding treatments, and we remain a
strong supporter for diabetes prevention, research and treatment. Our company will continue to
provide our members with helpful resources on awareness, as well as access to quality
healthcare.

About Blue Cross and Blue Shield of Alabama
Blue Cross and Blue Shield of Alabama has insured Alabamians for 80 years.
Blue Cross offers coverage plans to corporations, individuals and the senior market. For more
information about Blue Cross, visit AlabamaBlue.com.
Blue Cross and Blue Shield of Alabama is an independent licensee of the Blue Cross and
Blue Shield Association.